96 related articles for article (PubMed ID: 21158893)
1. Prospective echocardiographic evaluation of patients with endogenous subclinical hyperthyroidism and after restoring euthyroidism.
Kaminski G; Michalkiewicz D; Makowski K; Podgajny Z; Szalus N; Ruchala M; Szczepanek E; Gielerak G
Clin Endocrinol (Oxf); 2011 Apr; 74(4):501-7. PubMed ID: 21158893
[TBL] [Abstract][Full Text] [Related]
2. Quality of life in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomized controlled trial.
Eustatia-Rutten CF; Corssmit EP; Pereira AM; Frölich M; Bax JJ; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2006 Mar; 64(3):284-91. PubMed ID: 16487438
[TBL] [Abstract][Full Text] [Related]
3. Glucose tolerance and lipid profile in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomised controlled trial.
Heemstra KA; Smit JW; Eustatia-Rutten CF; Heijboer AC; Frölich M; Romijn JA; Corssmit EP
Clin Endocrinol (Oxf); 2006 Dec; 65(6):737-44. PubMed ID: 17121524
[TBL] [Abstract][Full Text] [Related]
4. Prompt treatment of hypothyroidism following radioiodine therapy: impact on thyroid function and mortality.
Kahaly GJ
Nat Clin Pract Endocrinol Metab; 2006 Mar; 2(3):134-5. PubMed ID: 16932271
[No Abstract] [Full Text] [Related]
5. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
[TBL] [Abstract][Full Text] [Related]
6. Screening of geriatric patients for thyroid dysfunction with thyrotropin-releasing-hormone test, sensitive thyrotropin and free thyroxine estimation.
Szabolcs I; Ploenes C; Bernard W; Herrmann J
Horm Metab Res; 1990 May; 22(5):298-302. PubMed ID: 2112111
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of hyperthyroidism with radioiodine: effects of administered dose on complications and thyroid function].
Pineda P; Michelsen H; Rivera M; Lillo R; Massardo T; Araya V; Sierralta P; Oviedo S; Liberman C
Rev Med Chil; 2000 May; 128(5):499-507. PubMed ID: 11008353
[TBL] [Abstract][Full Text] [Related]
8. Radioactive iodine therapy in Graves' hyperthyroidism: a prospective study from a tertiary referral centre in north India.
Sankar R; Sekhri T; Sripathy G; Walia RP; Jain SK
J Assoc Physicians India; 2005 Jul; 53():603-6. PubMed ID: 16190128
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus.
Celani MF; Bonati ME; Stucci N
Diabetes Res; 1994; 27(1):15-25. PubMed ID: 7648793
[TBL] [Abstract][Full Text] [Related]
10. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
[TBL] [Abstract][Full Text] [Related]
11. [Follow-up studies of patients with negative TRH test and normal thyroid hormone levels].
Döge H; Hübner O; Kempe K; Riedel A; Ortweiler W
Z Gesamte Inn Med; 1993 Aug; 48(8):398-400. PubMed ID: 8379222
[TBL] [Abstract][Full Text] [Related]
12. [Improved evaluation criteria of autonomous thyroid adenoma: triiodothyronine concentration in serum, functional definition through TRH test].
Wenzel KW; Meinhold H; Schleusener H; Botsch H
Dtsch Med Wochenschr; 1974 Jul; 99(27):1465-73. PubMed ID: 4135676
[No Abstract] [Full Text] [Related]
13. Serum T3, T4, TSH patterns in euthyroid subjects treated with 131I for thyrotoxicosis.
Biassoni P; Bagnasco M; Caputo M; Santaniello B; Ferrini O
J Nucl Med Allied Sci; 1980; 24(1-2):93-8. PubMed ID: 7205396
[No Abstract] [Full Text] [Related]
14. Isolated high serum triiodothyronine levels. Clinical relevance after sodium iodide I 131 therapy.
Soler NG; Kennedy W; Wortsman J
Arch Intern Med; 1979 Jan; 139(1):36-8. PubMed ID: 760681
[TBL] [Abstract][Full Text] [Related]
15. Autonomic nervous system function in chronic exogenous subclinical thyrotoxicosis and the effect of restoring euthyroidism.
Eustatia-Rutten CF; Corssmit EP; Heemstra KA; Smit JW; Schoemaker RC; Romijn JA; Burggraaf J
J Clin Endocrinol Metab; 2008 Jul; 93(7):2835-41. PubMed ID: 18397977
[TBL] [Abstract][Full Text] [Related]
16. [Assessment of basal and stimulated TSH in overt and subclinical hyperthyroidism].
Reinhardt M; Schümichen C; Schächtele S; Zimmerlin M; Moser E
Nuklearmedizin; 1995 Apr; 34(2):61-5. PubMed ID: 7761275
[TBL] [Abstract][Full Text] [Related]
17. [Subclinical thyroid disorders].
Krysiak R; Okopień B; Herman ZS
Pol Merkur Lekarski; 2006 Dec; 21(126):573-8. PubMed ID: 17405301
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of two different dosage calculation protocols of iodine-131 in the treatment of hyperthyroidism.
Thientunyakit T; Thongmak S; Premprapha T
J Med Assoc Thai; 2010 Aug; 93(8):969-77. PubMed ID: 20718174
[TBL] [Abstract][Full Text] [Related]
19. Hyperthyroidism and excessive thyrotropin secretion.
Emerson CH; Utiger RD
N Engl J Med; 1972 Aug; 287(7):328-33. PubMed ID: 4114408
[No Abstract] [Full Text] [Related]
20. [Pursued objectives with the use of 131I for the treatment of hypothyroidism: analysis of 2 series receiving different doses].
Aguayo J; Atria A; Pineda G
Rev Med Chil; 1987 Apr; 115(4):308-13. PubMed ID: 3448739
[No Abstract] [Full Text] [Related]
[Next] [New Search]
